title: Brief report: treatment of a laboratory-acquired Sabiá virus infection.
authors.affiliation: Department of Internal Medicine, Yale University School of Medicine, New Haven, Conn. 06504, USA.
authors.forename: M
authors.initials: M
authors.lastname: Barry
authors.forename: M
authors.initials: M
authors.lastname: Russi
authors.forename: L
authors.initials: L
authors.lastname: Armstrong
authors.forename: D
authors.initials: D
authors.lastname: Geller
authors.forename: R
authors.initials: R
authors.lastname: Tesh
authors.forename: L
authors.initials: L
authors.lastname: Dembry
authors.forename: J P
authors.initials: JP
authors.lastname: Gonzalez
authors.forename: A S
authors.initials: AS
authors.lastname: Khan
authors.forename: C J
authors.initials: CJ
authors.lastname: Peters
mesh_terms: D006477:Arenaviruses, New World; D001938:Brazil; D016358:Contact Tracing; D006478:Hemorrhagic Fever, American / Q000188:drug therapy* / Q000821:virology; D006801:Humans; D017053:Infection Control / Q000379:methods*; D007757:Laboratory Infection / Q000188:drug therapy* / Q000821:virology; D008297:Male; D008875:Middle Aged; D010356:Patient Isolation; D012254:Ribavirin / Q000627:therapeutic use*; D017751:Safety Management / Q000379:methods; D016635:Universal Precautions
chemical_list: D012254:Ribavirin